about
Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokineticsRadiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECTEvaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability.Molecular profiling of angiogenic markers: a step towards interpretive analysis of a complex biological function.Construction of expressing vectors including melanoma differentiation-associated gene-7 (mda-7) fused with the RGD sequences for better tumor targetingColigand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramerLinker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimerImproving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkersImproving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkersNoninvasive monitoring of HPMA copolymer-RGDfK conjugates by magnetic resonance imaging.Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.(99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression
P2860
Q33867187-29E11064-16D9-4EF8-9B27-1B078ABC98A0Q33925952-C88390B5-00C9-4D75-997A-76F8C0F6945CQ34912643-32B4B7C1-D08B-43B0-AC4A-13D0169DA27FQ35167459-3E41C030-5EC7-41E9-8C32-142D469635C6Q35747405-2E71C818-0E40-4BEB-9432-522D96D1E4EDQ36249337-DF404907-3966-48AC-A5BA-10C15B40D727Q36515561-3480483B-8E8A-44E2-A391-A06A2F3818DCQ36865548-DFF9DA0E-336C-4252-832F-D7D442A697F6Q37060623-4134F90F-E5BB-4F10-AD48-32B34C907DA8Q37081396-2AD44026-242C-4C26-BDDD-59D32C17A611Q37178786-C1F801A3-C4D4-4349-BCE4-CD991B497E42Q37325981-0D1109EC-3CF8-40D7-95A2-7C4F12EE3361Q37480688-0F24CEBC-2529-4951-BB4A-B25F2F05A29FQ37624526-5199AD14-1D5A-4E53-9962-FDD1AF4B64D9Q42738940-26042728-7290-4A43-B829-3448F55BFDC0
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Tumor angiogenesis targeting using imaging agents.
@ast
Tumor angiogenesis targeting using imaging agents.
@en
Tumor angiogenesis targeting using imaging agents.
@nl
type
label
Tumor angiogenesis targeting using imaging agents.
@ast
Tumor angiogenesis targeting using imaging agents.
@en
Tumor angiogenesis targeting using imaging agents.
@nl
prefLabel
Tumor angiogenesis targeting using imaging agents.
@ast
Tumor angiogenesis targeting using imaging agents.
@en
Tumor angiogenesis targeting using imaging agents.
@nl
P2093
P1476
Tumor angiogenesis targeting using imaging agents
@en
P2093
P304
P577
2001-06-01T00:00:00Z